Never miss an update from Exelixis. Did you know that during reporting season, the announcements from NASDAQ:EXEL often move the market?
|52w High/Low:||$15.02 - 25.31|
|Volume/Average:||4.1M - 3.6M|
Listed in 2000Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer... More
Cabozantinib may help delay the need for chemotherapy in advanced patients.3 Stocks I'll Never Sell
These businesses have proved they can stand the test of time.3 Cancer Treatment Stocks to Buy Right Now
These three companies are innovators in the development of cancer drugs, and they can also make you a lot of money.Can Investors Excel in 2020 With Exelixis?
This pharma stock can look forward to a year with more readouts, potential approvals, and new clinical assets providing value in the oncology space.5 Value Stocks That Will Make You Richer in 2020
Bargains abound for patient long-term investors.10 Top Stocks That Will Make You Richer in 2020
Start the year off right by investing in these top-tier companies.2 Incredibly Cheap Biotech Stocks
These promising stocks have been flying under the radar this year, but they're worth another look.3 Top Growth Stocks to Buy in December
These three names could soar early in 2020.